BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22993324)

  • 1. Serum platelet-derived growth factor and fibroblast growth factor in patients with benign and malignant ovarian tumors.
    Madsen CV; Steffensen KD; Olsen DA; Waldstrøm M; Søgaard CH; Brandslund I; Jakobsen A
    Anticancer Res; 2012 Sep; 32(9):3817-25. PubMed ID: 22993324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibrosarcoma-derived Schwann cells overexpress platelet-derived growth factor (PDGF) receptors and are induced to proliferate by PDGF BB.
    Badache A; De Vries GH
    J Cell Physiol; 1998 Nov; 177(2):334-42. PubMed ID: 9766530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis.
    Nissen LJ; Cao R; Hedlund EM; Wang Z; Zhao X; Wetterskog D; Funa K; Bråkenhielm E; Cao Y
    J Clin Invest; 2007 Oct; 117(10):2766-77. PubMed ID: 17909625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation.
    Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines.
    Apte SM; Bucana CD; Killion JJ; Gershenson DM; Fidler IJ
    Gynecol Oncol; 2004 Apr; 93(1):78-86. PubMed ID: 15047217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation and maturation of intratumoral blood vessels in women with malignant ovarian tumors assessed with cancer stem cells marker nestin and platelet derived growth factor PDGF-B.
    Czekierdowska S; Stachowicz N; Chróściel M; Czekierdowski A
    Ginekol Pol; 2017; 88(3):120-128. PubMed ID: 28397199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.
    Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
    J Thorac Oncol; 2009 May; 4(5):578-85. PubMed ID: 19318994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-derived growth factor (subtype BB) is elevated in patients with colorectal carcinoma.
    Belizon A; Balik E; Horst PK; Shantha Kumara HM; Nasar A; Whelan RL
    Dis Colon Rectum; 2009 Jun; 52(6):1166-71. PubMed ID: 19581863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab.
    Madsen CV; Steffensen KD; Olsen DA; Waldstrøm M; Smerdel M; Adimi P; Brandslund I; Jakobsen A
    J Ovarian Res; 2012 Sep; 5(1):23. PubMed ID: 22989094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms.
    Henriksen R; Funa K; Wilander E; Bäckström T; Ridderheim M; Oberg K
    Cancer Res; 1993 Oct; 53(19):4550-4. PubMed ID: 8402626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer.
    Lindmark G; Sundberg C; Glimelius B; Påhlman L; Rubin K; Gerdin B
    Lab Invest; 1993 Dec; 69(6):682-9. PubMed ID: 8264231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor, epidermal growth factor, insulin-like growth factors, and platelet-derived growth factor-BB stimulate proliferation of clonally derived porcine myogenic satellite cells.
    Doumit ME; Cook DR; Merkel RA
    J Cell Physiol; 1993 Nov; 157(2):326-32. PubMed ID: 8227164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of platelet-derived growth factor-BB and vascular endothelial growth factor as prognostic factors for patients with fulminant hepatic failure.
    Takayama H; Miyake Y; Nouso K; Ikeda F; Shiraha H; Takaki A; Kobashi H; Yamamoto K
    J Gastroenterol Hepatol; 2011 Jan; 26(1):116-21. PubMed ID: 21175804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of implantation of Augment(®) Bone Graft on serum concentrations of platelet-derived growth factors: a pharmacokinetic study.
    Solchaga LA; Daniels T; Roach S; Beasley W; Snel LB
    Clin Drug Investig; 2013 Feb; 33(2):143-9. PubMed ID: 23334906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta, basic fibroblast growth factor, and platelet-derived growth factor-BB interact to affect proliferation of clonally derived porcine satellite cells.
    Cook DR; Doumit ME; Merkel RA
    J Cell Physiol; 1993 Nov; 157(2):307-12. PubMed ID: 8227163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in serum platelet-derived growth factor (PDGF)-BB reflects lymph node involvement in esophageal cancer patients independently from platelet count.
    Krzystek-Korpacka M; Diakowska D; Gamian A; Matusiewicz M
    Exp Oncol; 2011 Sep; 33(3):140-4. PubMed ID: 21956466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet Derived Growth Factor BB: A "Must-have" Therapeutic Target "Redivivus" in Ovarian Cancer.
    Cimpean AM; Cobec IM; Ceaușu RA; Popescu R; Tudor A; Raica M
    Cancer Genomics Proteomics; 2016 11-12; 13(6):511-517. PubMed ID: 27807074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between serum platelet-derived growth factor BB and degree of liver damage, fibrosis and hepatitis B e antigen (HBeAg) status in CHB patients.
    Diang XC; Ma LN; Li YF; Liu XY; Zhang X; Liu JY; Sheng YJ; Zhang DZ; Hu HD; Ren H
    Hepatogastroenterology; 2012; 59(120):2357-60. PubMed ID: 22688015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of platelet-derived growth factor-BB following modification by ADP-ribosyltransferase.
    Saxty BA; Yadollahi-Farsani M; Upton PD; Johnstone SR; MacDermot J
    Br J Pharmacol; 2001 Aug; 133(8):1219-26. PubMed ID: 11498506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies.
    Jean M; Smaoui F; Lavertu M; Méthot S; Bouhdoud L; Buschmann MD; Merzouki A
    Gene Ther; 2009 Sep; 16(9):1097-110. PubMed ID: 19440230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.